These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22126980)

  • 1. Sugars and alcohol: IgA-associated renal diseases in alcoholic cirrhosis.
    Novak J; Julian BA
    Kidney Int; 2011 Dec; 80(12):1252-4. PubMed ID: 22126980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
    Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC
    Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
    Berthelot L; Robert T; Vuiblet V; Tabary T; Braconnier A; Dramé M; Toupance O; Rieu P; Monteiro RC; Touré F
    Kidney Int; 2015 Oct; 88(4):815-22. PubMed ID: 26061544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction.
    Papista C; Lechner S; Ben Mkaddem S; LeStang MB; Abbad L; Bex-Coudrat J; Pillebout E; Chemouny JM; Jablonski M; Flamant M; Daugas E; Vrtovsnik F; Yiangou M; Berthelot L; Monteiro RC
    Kidney Int; 2015 Aug; 88(2):276-85. PubMed ID: 25807036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal systems of immunoglobulin A and immunoglobulin A containing complexes in IgA nephropathy and cirrhosis patients. The role of asialoglycoprotein receptors.
    Roccatello D; Picciotto G; Torchio M; Ropolo R; Ferro M; Franceschini R; Quattrocchio G; Cacace G; Coppo R; Sena LM
    Lab Invest; 1993 Dec; 69(6):714-23. PubMed ID: 8264233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary IgA nephropathy: new insights into pathogenesis.
    Barratt J; Feehally J
    Semin Nephrol; 2011 Jul; 31(4):349-60. PubMed ID: 21839368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of IgA receptors in the pathogenesis of IgA nephropathy.
    Lechner SM; Papista C; Chemouny JM; Berthelot L; Monteiro RC
    J Nephrol; 2016 Feb; 29(1):5-11. PubMed ID: 26572664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy.
    Xu L; Li B; Huang M; Xie K; Li D; Li Y; Gu H; Fang J
    PLoS One; 2016; 11(7):e0159426. PubMed ID: 27437939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of Fc alpha receptors on blood cells of IgA nephropathy patients: evidence for a negative regulatory role of serum IgA.
    Grossetête B; Launay P; Lehuen A; Jungers P; Bach JF; Monteiro RC
    Kidney Int; 1998 May; 53(5):1321-35. PubMed ID: 9573548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights in the pathogenesis of IgA nephropathy.
    Monteiro RC
    Nefrologia; 2005; 25 Suppl 2():82-6. PubMed ID: 16050408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogenesis of Berger's disease: recent advances on the involvement of immunoglobulin A and their receptors].
    Monteiro RC; Leroy V; Launay P; Moura IC; Arcos-Fajardo M; Benhamou M; Haddad E
    Med Sci (Paris); 2003 Dec; 19(12):1233-41. PubMed ID: 14691748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoids Reduce Aberrant O-Glycosylation of IgA1 in IgA Nephropathy Patients.
    Kosztyu P; Hill M; Jemelkova J; Czernekova L; Kafkova LR; Hruby M; Matousovic K; Vondrak K; Zadrazil J; Sterzl I; Mestecky J; Raska M
    Kidney Blood Press Res; 2018; 43(2):350-359. PubMed ID: 29529610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
    Barratt J; Smith AC; Feehally J
    Nephrology (Carlton); 2007 Jun; 12(3):275-84. PubMed ID: 17498123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
    Novak J; Moldoveanu Z; Julian BA; Raska M; Wyatt RJ; Suzuki Y; Tomino Y; Gharavi AG; Mestecky J; Suzuki H
    Adv Otorhinolaryngol; 2011; 72():60-3. PubMed ID: 21865691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of macromolecular IgA in IgA nephropathy.
    van der Boog PJ; van Kooten C; de Fijter JW; Daha MR
    Kidney Int; 2005 Mar; 67(3):813-21. PubMed ID: 15698421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating CD89-IgA complex does not predict deterioration of kidney function in Korean patients with IgA nephropathy.
    Jhee JH; Kang HY; Wu M; Nam BY; Chang TI; Jung SY; Park S; Kim H; Yun HR; Kee YK; Yoon CY; Park JT; Yoo TH; Kang SW; Han SH
    Clin Chem Lab Med; 2017 Nov; 56(1):75-85. PubMed ID: 28672768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Fc-receptor blocking factors in IgA nephropathies.
    Roccatello D; Coppo R; Piccoli G; Cordonnier D; Martina G; Rollino C; Picciotto G; Sena LM; Amoroso A
    Clin Nephrol; 1985 Apr; 23(4):159-68. PubMed ID: 3874036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgA, glomerulonephritis and liver disease.
    Woodroffe AJ
    Aust N Z J Med; 1981; 11(Suppl 1):109-11. PubMed ID: 6942798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgA nephropathy enigma.
    Mestecky J; Novak J; Moldoveanu Z; Raska M
    Clin Immunol; 2016 Nov; 172():72-77. PubMed ID: 27444044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complexes of IgA with FcalphaRI/CD89 are not specific for primary IgA nephropathy.
    van der Boog PJ; De Fijter JW; Van Kooten C; Van Der Holst R; Van Seggelen A; Van Es LA; Daha MR
    Kidney Int; 2003 Feb; 63(2):514-21. PubMed ID: 12631116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.